Literature DB >> 8106600

Polymerase chain reaction detection of human cytomegalovirus in over 2000 blood specimens correlated with virus isolation and related to urinary virus excretion.

E Drouet1, S Michelson, G Denoyel, R Colimon.   

Abstract

The polymerase chain reaction (PCR) as applied to human cytomegalovirus (HCMV) detection should provide a valuable tool for rapid, reliable diagnosis of infection, thereby allowing prompt treatment. However, to date the high sensitivity of this technique and the lack of semi-quantitative interpretation have hindered establishing its validity for diagnosing systemic infection. We describe a rapid, simple, semi-quantitative PCR technique for HCMV detection. The validity of the technique was tested objectively by analyzing over 2000 leukocytes specimens by PCR and comparing the results with virus isolation from urine and blood in concomitant samples in the absence of any clinical data. It could thus be established that this technique had a sensitivity and specificity of 97%. When the PCR signal corresponded to > or = 8000 genome equivalents for 10(4) leukocytes, the predictive value for viremia was 86%. This semi-quantitative PCR technique should allow rapid diagnosis of systemic infection and provide a reliable means of monitoring clearance of CMV from blood during drug therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8106600     DOI: 10.1016/0166-0934(93)90112-5

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  13 in total

1.  A highly sensitive assay for detection and quantitation of human cytomegalovirus DNA in serum and plasma by PCR and electrochemiluminescence.

Authors:  R Boom; C Sol; J Weel; Y Gerrits; M de Boer; P Wertheim-van Dillen
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  Evaluation of PCR primers for cytomegalovirus detection.

Authors:  A Weinberg; S Li
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

3.  Evaluation of the COBAS AMPLICOR CMV MONITOR test for detection of viral DNA in specimens taken from patients after liver transplantation.

Authors:  I G Sia; J A Wilson; M J Espy; C V Paya; T F Smith
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  Evaluation of PCR primers for early diagnosis of cytomegalovirus infection following liver transplantation.

Authors:  J C Mendez; M J Espy; T F Smith; J A Wilson; C V Paya
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

5.  Human cytomegalovirus DNA in plasma and serum specimens of renal transplant recipients is highly fragmented.

Authors:  René Boom; Cees J A Sol; Tim Schuurman; Alex Van Breda; Jan F L Weel; Marcel Beld; Ineke J M Ten Berge; Pauline M E Wertheim-Van Dillen; Menno D De Jong
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

Review 6.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 7.  Quantitative PCR. A survey of the present technology.

Authors:  U Reischl; B Kochanowski
Journal:  Mol Biotechnol       Date:  1995-02       Impact factor: 2.695

8.  Monitoring levels of human cytomegalovirus DNA in blood after liver transplantation.

Authors:  E Drouet; R Colimon; S Michelson; N Fourcade; A Niveleau; C Ducerf; A Boibieux; M Chevallier; G Denoyel
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

9.  Qualitative and semiquantitative polymerase chain reaction testing for cytomegalovirus DNA in serum allows prediction of CMV related disease in liver transplant recipients.

Authors:  P C Evans; A Soin; T G Wreghitt; G J Alexander
Journal:  J Clin Pathol       Date:  1998-12       Impact factor: 3.411

10.  Detection and semiquantitative analysis of human herpesvirus 8 DNA in specimens from patients with Kaposi's sarcoma.

Authors:  J C Mendez; G W Procop; M J Espy; C V Paya; T F Smith
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.